Showing results (2271-2280 of 22,048) with videos related to
Sort By:
Pageof 2,205
Oncogene|July 15, 2009
Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrinX Wan, S Y Kim, L M Guenther, et al.Oncogene|July 15, 2009
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signalingA H Palamakumbura, S R Vora, M A Nugent, et al.Oncogene|July 15, 2009
PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancersP Klanrit, P Taebunpakul, M B Flinterman, et al.Oncogene|August 25, 2009
Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expressionS Kaulfuss, S von Hardenberg, S Schweyer, et al.Oncogene|August 25, 2009
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancerX-F Li, P-J Yan, Z-M ShaoOncogene|April 1, 1990
Transforming genes from familial adenomatous polyposis patient cells detected by a tumorigenicity assayY Yuasa, T Kamiyama, M Kato, et al.Oncogene|August 12, 2009
Paclitaxel promotes a caspase 8-mediated apoptosis through death effector domain association with microtubulesA Mielgo, V A Torres, K Clair, et al.Oncogene|August 12, 2009
The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastomaG P Atkinson, S E Nozell, D K Harrison, et al.Oncogene|August 12, 2009
Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1H-Q Zheng, Z Zhou, J Huang, et al.Oncogene|August 18, 2009
Nuclear EGFR contributes to acquired resistance to cetuximabC Li, M Iida, E F Dunn, et al.Pageof 2,205